MAP Pharmaceuticals

PharmaceuticalsSeries DMountain View, USmappharma.com

Latest round

Series D

Last raised

Mar 2007

Total raised

$105M

Investors

7

About MAP Pharmaceuticals

MAP Pharmaceuticals is based in Mountain View, US and is an innovative drug company focused on providing better treatments for patients with neurological diseases.

Who invested in MAP Pharmaceuticals

7 investors across 3 rounds

See all investors in MAP Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Mar 27, 2007

    Amount

    $50M

    Investors

    Locked

  2. Series C

    Jan 25, 2006

    Amount

    $25M

    Investors

    Locked

  3. Series B

    Sep 7, 2004

    Amount

    $30M

    Investors

    Locked

Questions about MAP Pharmaceuticals

Who invested in MAP Pharmaceuticals?

MAP Pharmaceuticals has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has MAP Pharmaceuticals raised?

MAP Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did MAP Pharmaceuticals last raise money?

MAP Pharmaceuticals's most recent round on record is a Series D, in Mar 2007.

What does MAP Pharmaceuticals do?

MAP Pharmaceuticals is based in Mountain View, US and is an innovative drug company focused on providing better treatments for patients with neurological diseases.

Where is MAP Pharmaceuticals headquartered?

MAP Pharmaceuticals is headquartered in Mountain View, US.

Which VCs invest in companies like MAP Pharmaceuticals?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at MAP Pharmaceuticals's stage. Their profiles are linked below.

Raising like MAP Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.